The current pharmaceutical landscape is witnessing a profound transformation as the successful
CordenPharma is proactively responding to the evolving healthcare landscape by enhancing its
The traditional labor-intensive process of utilizing high-resolution imaging and biochemical assays to map binding sites often spans several years. This bottleneck has long hindered the pace of pharmaceutical innovation, forcing researchers to rely on trial-and-error methods that consume vast
While medication abortion is FDA-approved for use up to eleven weeks of pregnancy, a new legal effort argues that state-level bans are being undermined by mail-order access. This challenge, currently centered in Louisiana, targets the regulatory framework that allows physicians to prescribe
Personalized medicine is emerging as a primary catalyst for manufacturing innovation, requiring
Industry groups are requesting concrete examples of how prior clinical data can be used to optimize
In 2026, boards and customers are asking a direct question: can promising science be turned into reliable, affordable systems that deliver audited outcomes at scale, quarter after quarter, without…
The partnership between Eli Lilly and NVIDIA to build a supercomputer capable of running trillions
The biopharma playbook is being actively rewritten. After years of chasing breakthrough science at
The pharmaceutical sector is entering a decisive phase as obesity therapeutics gain more ground as
Advanced Therapy Medicinal Products cannot be scaled the same way biologics were. The core
The move to categorize cardiovascular machine learning software under regulation 21 CFR 870.2380 creates a new benchmark for medical technology safety. This initiative by the U.S. Food and Drug Administration clarifies the expectations for how digital tools are developed, validated, and brought to
As the healthcare system becomes more integrated, the increasing number of stakeholders with
The ability to reconstruct the history of our species using ancestral recombination graphs has
